143 related articles for article (PubMed ID: 23611475)
1. Physicochemical characterization of nimodipine-polyethylene glycol solid dispersion systems.
Barmpalexis P; Kachrimanis K; Georgarakis E
Drug Dev Ind Pharm; 2014 Jul; 40(7):886-95. PubMed ID: 23611475
[TBL] [Abstract][Full Text] [Related]
2. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming.
Barmpalexis P; Kachrimanis K; Georgarakis E
Eur J Pharm Biopharm; 2011 Jan; 77(1):122-31. PubMed ID: 20934511
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
Urbanetz NA
Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
[TBL] [Abstract][Full Text] [Related]
4. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
Smikalla MM; Urbanetz NA
Eur J Pharm Biopharm; 2007 Apr; 66(1):106-12. PubMed ID: 17055711
[TBL] [Abstract][Full Text] [Related]
5. Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approach.
Rahman Z; Siddiqui A; Khan MA
Int J Pharm; 2013 Oct; 455(1-2):113-23. PubMed ID: 23911342
[TBL] [Abstract][Full Text] [Related]
6. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterisations of the physical, solid dispersed and eutectic mixtures.
Naima Z; Siro T; Juan-Manuel GD; Chantal C; René C; Jerome D
Eur J Pharm Sci; 2001 Feb; 12(4):395-404. PubMed ID: 11231106
[TBL] [Abstract][Full Text] [Related]
7. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
8. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
10. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.
Zheng X; Yang R; Tang X; Zheng L
Drug Dev Ind Pharm; 2007 Jul; 33(7):791-802. PubMed ID: 17654028
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine.
Murali Mohan Babu GV; Prasad ChD; Ramana Murthy KV
Int J Pharm; 2002 Mar; 234(1-2):1-17. PubMed ID: 11839433
[TBL] [Abstract][Full Text] [Related]
13. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
14. Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions.
Mirza S; Heinämäki J; Miroshnyk I; Rantanen J; Christiansen L; Karjalainen M; Yliruusi J
J Pharm Sci; 2006 Aug; 95(8):1723-32. PubMed ID: 16795009
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterisation.
Urbanetz NA; Lippold BC
Eur J Pharm Biopharm; 2005 Jan; 59(1):107-18. PubMed ID: 15567307
[TBL] [Abstract][Full Text] [Related]
17. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
Khattab IS; Nada A; Zaghloul AA
Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
[TBL] [Abstract][Full Text] [Related]
19. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
